chr11-89284787-G-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000372.5(TYR):c.1199G>T(p.Trp400Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000807 in 1,611,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W400C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000372.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYR | NM_000372.5 | c.1199G>T | p.Trp400Leu | missense_variant | 4/5 | ENST00000263321.6 | NP_000363.1 | |
TYR | XM_011542970.3 | c.1199G>T | p.Trp400Leu | missense_variant | 4/6 | XP_011541272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYR | ENST00000263321.6 | c.1199G>T | p.Trp400Leu | missense_variant | 4/5 | 1 | NM_000372.5 | ENSP00000263321.4 | ||
TYR | ENST00000528243.1 | n.197G>T | non_coding_transcript_exon_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151760Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250296Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135310
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1459682Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726202
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151760Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74106
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces tryptophan, which is neutral and slightly polar, with leucine, which is neutral and non-polar, at codon 400 of the TYR protein (p.Trp400Leu). This variant is present in population databases (rs62645916, gnomAD 0.05%). This missense change has been observed in individuals with non-syndromic ocular albinism (PMID: 31077556). ClinVar contains an entry for this variant (Variation ID: 99541). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31199599, 19865097, 26165494, 31196117, 29658579, 22875490, 29437493, 20447099, 31229681, 25577957, 31077556, 10571953, 16570240, 22097729, 15591842, 30868138) - |
Tyrosinase-negative oculocutaneous albinism Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 31, 2016 | - - |
Oculocutaneous albinism type 1B;C2677190:SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;C4551504:Tyrosinase-negative oculocutaneous albinism Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 22, 2024 | - - |
Oculocutaneous albinism type 1B;C2677190:SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;C4551504:Tyrosinase-negative oculocutaneous albinism;CN028925:Ocular albinism with congenital sensorineural hearing loss Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
TYR-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 30, 2024 | The TYR c.1199G>T variant is predicted to result in the amino acid substitution p.Trp400Leu. This variant has been reported as causative for autosomal recessive oculocutaneous albinism (Tsai et al. 1999. PubMed ID: 10571953; Liu et al. 2010. PubMed ID: 20447099; Wei et al. 2010. PubMed ID: 19865097; Zhong et al. 2019. PubMed ID: 31077556). This variant is reported in 0.050% of alleles in individuals of East Asian descent in gnomAD. Given the evidence, we interpret this variant as pathogenic. - |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 27, 2024 | - - |
Oculocutaneous albinism type 1B;C4551504:Tyrosinase-negative oculocutaneous albinism Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM3_VeryStrong+PP4+PM2_Supporting+PP3_Strong - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at